NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Wednesday a 27 percent drop in revenues year over year for the fourth quarter.
For the three months ended Dec. 31, 2017, the Temple City, California-based genetic testing firm posted $4.3 million in revenues, down from $5.9 million in Q4 2016.